Real-time enrollment status for this hiv infections clinical trial
Current Status
Recruiting
Checked: August 14, 2026 at 6:53 PM UTC
| NCT Number | NCT07682961 |
| Recruiting Status | Recruiting |
| Condition | HIV Infections |
| Phase | PHASE3 |
| Target Enrollment | 590 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | August 14, 2026 (18 hours ago) |
As of August 14, 2026: Clinical trial NCT07682961 is currently recruiting participants. This phase3 study for hiv infections is actively seeking new participants at 16 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07682961 is actively recruiting participants as of August 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07682961 was last updated 18 hours ago (August 14, 2026). HelloStudys verifies this status automatically.